Take Solutions Ltd. | Small-cap | Healthcare
₹11.40
-1.55%
| Take Solutions Stock Comparison:
Take Solutions vs BioconTake Solutions vs OneSource SpecialtyTake Solutions vs Dishman CarbogenTake Solutions vs Zota Health CareTake Solutions vs Panacea BiotecTake Solutions vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 0
Gross Profit 0
Operating Income -11.5M
Net Income -48.8M

Balance Sheet Metrics

Total Assets 364.8M
Total Liabilities 159.5M
Shareholders Equity 205.3M
Debt to Equity 0.78

Cash Flow Metrics

Revenue & Profitability Trend

Take Solutions Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i0656.1M1.9B6.5B7.7B
Cost of Goods Sold i0244.4M830.1M1.9B1.9B
Gross Profit i0411.7M1.1B4.6B5.9B
Gross Margin % i0.0%62.7%56.1%70.5%75.7%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i-79.3M102.9M793.4M757.0M
Other Operating Expenses i63.8M134.0M228.5M537.8M629.6M
Total Operating Expenses i63.8M213.3M331.4M1.3B1.4B
Operating Income i-75.2M-56.1M58.2M-601.1M-1.5B
Operating Margin % i0.0%-8.6%3.1%-9.2%-19.4%
Non-Operating Items
Interest Income i-4.9M8.3M7.3M9.0M
Interest Expense i19.6M54.3M71.0M270.4M294.6M
Other Non-Operating Income-----
Pre-tax Income i7.4M-1.2B-452.7M-780.0M-4.4B
Income Tax i012.3M16.8M48.4M135.5M
Effective Tax Rate % i0.0%0.0%0.0%0.0%0.0%
Net Income i374.7M-1.2B-1.0B-7.8B-4.5B
Net Margin % i0.0%-182.3%-53.1%-119.9%-58.1%
Key Metrics
EBITDA i27.4M-484.6M303.3M503.3M-371.8M
EPS (Basic) i₹2.56₹-8.18₹-6.86₹-53.50₹-30.91
EPS (Diluted) i₹2.56₹-8.18₹-6.86₹-53.50₹-30.91
Basic Shares Outstanding i146355469146224984146224984146224984146224984
Diluted Shares Outstanding i146355469146224984146224984146224984146224984

Income Statement Trend

Take Solutions Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i33.7M8.4M107.2M290.0M324.2M
Short-term Investments i123.2M5.8M6.1M60.4M1.3B
Accounts Receivable i070.4M300.4M815.0M4.3B
Inventory i08.0M7.8M6.5M6.0M
Other Current Assets78.6M20.0K10.0K10.0K-20.0K
Total Current Assets i235.5M352.8M901.9M10.9B8.6B
Non-Current Assets
Property, Plant & Equipment i-285.0M195.3M450.7M2.3B
Goodwill i80.0K17.5M1.1B1.1B12.1B
Intangible Assets i80.0K17.5M20.6M25.0M2.1B
Long-term Investments-----
Other Non-Current Assets-10.1M255.9M-30.0K20.0K
Total Non-Current Assets i129.3M528.2M1.3B1.4B9.8B
Total Assets i364.8M881.0M2.2B12.2B18.4B
Liabilities
Current Liabilities
Accounts Payable i14.8M174.3M236.2M287.9M415.5M
Short-term Debt i0305.1M324.5M501.9M3.9B
Current Portion of Long-term Debt-----
Other Current Liabilities57.2M261.8M348.3M-10.0K20.0K
Total Current Liabilities i159.5M891.6M1.0B10.1B5.2B
Non-Current Liabilities
Long-term Debt i065.8M139.2M278.0M1.6B
Deferred Tax Liabilities i---0266.2M
Other Non-Current Liabilities----10.0K10.0K
Total Non-Current Liabilities i-20.0K78.2M148.8M357.2M2.0B
Total Liabilities i159.5M969.8M1.2B10.4B7.2B
Equity
Common Stock i146.2M146.2M146.2M146.2M146.2M
Retained Earnings i--7.0B-5.8B-5.0B2.8B
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i205.3M-88.7M1.1B1.8B11.2B
Key Metrics
Total Debt i0370.8M463.7M779.9M5.5B
Working Capital i76.0M-538.8M-107.1M795.7M3.4B

Balance Sheet Composition

Take Solutions Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i374.4M-1.2B-986.7M-7.7B-4.4B
Depreciation & Amortization i-----
Stock-Based Compensation i-050.0K3.8M15.7M
Working Capital Changes i-69.4M107.7M49.2M-127.7M1.8B
Operating Cash Flow i222.1M-1.0B-871.2M-7.5B-2.2B
Investing Activities
Capital Expenditures i0-78.1M-318.8M-312.1M-17.9M
Acquisitions i219.8M0297.0M0-559.6M
Investment Purchases i---680.0K-1.7M-
Investment Sales i-3.5M297.0M0-
Investing Cash Flow i219.8M-74.6M274.4M-313.8M-577.6M
Financing Activities
Share Repurchases i-----
Dividends Paid i-390.0K-730.0K-680.0K-70.0K-
Debt Issuance i-----
Debt Repayment i-----
Financing Cash Flow i-390.0K-730.0K-680.0K-70.0K0
Free Cash Flow i-163.7M14.0M-123.8M891.0M1.3B
Net Change in Cash i441.5M-1.1B-597.4M-7.8B-2.8B

Cash Flow Trend

Take Solutions Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 58.39
Forward P/E 0.58
Price to Book 7.57
Price to Sales 3,748.35
PEG Ratio -0.76

Profitability Ratios

Profit Margin 98,304.88%
Operating Margin -1,892.68%
Return on Equity 182.53%
Return on Assets 102.71%

Financial Health

Current Ratio 1.48
Debt to Equity 0.00
Beta 0.48

Per Share Data

EPS (TTM) ₹0.18
Book Value per Share ₹1.39
Revenue per Share ₹0.00

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
take1.5B58.397.57182.53%98,304.88%0.00
Biocon 478.0B111.241.983.66%2.44%66.26
OneSource Specialty 208.0B-1,112.763.53-0.31%-0.85%16.03
Dishman Carbogen 41.3B1,253.100.710.06%3.60%40.97
Zota Health Care 34.7B-63.6837.52-38.38%-20.55%0.61
Panacea Biotec 25.1B91.933.00-1.01%1.88%2.67

Financial data is updated regularly. All figures are in the company's reporting currency.